Inhibrx Biosciences (INBX) Receivables (2023 - 2025)
Historic Receivables for Inhibrx Biosciences (INBX) over the last 3 years, with Q3 2025 value amounting to $837000.0.
- Inhibrx Biosciences' Receivables rose 2455.36% to $837000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $837000.0, marking a year-over-year increase of 2455.36%. This contributed to the annual value of $397000.0 for FY2024, which is 7133.57% down from last year.
- Latest data reveals that Inhibrx Biosciences reported Receivables of $837000.0 as of Q3 2025, which was up 2455.36% from $967000.0 recorded in Q2 2025.
- Inhibrx Biosciences' Receivables' 5-year high stood at $1.4 million during Q4 2023, with a 5-year trough of $214000.0 in Q1 2025.
- Its 3-year average for Receivables is $813571.4, with a median of $837000.0 in 2025.
- In the last 5 years, Inhibrx Biosciences' Receivables crashed by 7133.57% in 2024 and then soared by 2455.36% in 2025.
- Inhibrx Biosciences' Receivables (Quarter) stood at $1.4 million in 2023, then plummeted by 71.34% to $397000.0 in 2024, then surged by 110.83% to $837000.0 in 2025.
- Its last three reported values are $837000.0 in Q3 2025, $967000.0 for Q2 2025, and $214000.0 during Q1 2025.